JPM25: Incyte plans to turn 'a lot of cards' in 2025 as CEO eyes 2 types of deals

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a whirlwind tour of 18 events that could take place throughout 2025.